通过耗竭IGFBP3抑制肿瘤生长作为胶质瘤的潜在治疗策略
研究分析135例新诊断胶质瘤患者IGFBP3 RNA表达与临床病理因素的关系,发现IGFBP3在胶质母细胞瘤中表达高于肿瘤边缘和II级胶质瘤,高表达预示总生存期缩短;体外敲低IGFBP3抑制细胞增殖并诱导G2/M期阻滞和凋亡,小鼠颅内递送IGFBP3 siRNA可抑制肿瘤生长并延长生存。
要点
- IGFBP3在胶质母细胞瘤中表达高于肿瘤边缘和II级胶质瘤,且与肿瘤分级、组织学和IDH1/2突变状态相关。
- 高IGFBP3表达预示胶质瘤和胶质母细胞瘤前神经元亚组患者总生存期缩短。
- 小鼠颅内递送IGFBP3 siRNA可抑制颅内肿瘤生长并延长荷瘤小鼠生存。
核心结论
- 作者认为IGFBP3可预测胶质瘤患者不良预后,是潜在治疗靶点,耗竭其表达可通过诱导凋亡和DNA损伤积累抑制肿瘤生长。
研究设计与样本
- 研究纳入135例新诊断胶质瘤患者,分析IGFBP3 RNA表达与临床病理因素的相关性。
- 采用免疫组化检测胶质瘤标本IGFBP3蛋白表达。
- 使用IGFBP3敲低胶质瘤细胞进行体外细胞增殖实验。
- 在小鼠颅内异种移植模型中经颅内输注IGFBP3 siRNA评估耗竭效果。
- 另在小鼠皮下异种移植模型中观察IGFBP3敲低对体内肿瘤生长的影响。
主要发现
- 胶质母细胞瘤中IGFBP3表达高于肿瘤边缘和II级胶质瘤。
- IGFBP3表达与肿瘤分级正相关,并与肿瘤组织学和IDH1/2突变状态相关。
- 高IGFBP3表达预示胶质瘤和胶质母细胞瘤前神经元亚组患者总生存期缩短。
- 体外敲低IGFBP3抑制细胞增殖,诱导G2/M期阻滞和凋亡,并观察到DNA双链断裂和γH2AX积累。
- 小鼠皮下异种移植模型中敲低IGFBP3延迟体内肿瘤生长;小鼠脑内对流增强递送IGFBP3 siRNA抑制颅内肿瘤生长并延长荷瘤小鼠生存。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite intensive medical treatment, patients with glioblastoma (grade IV glioma [GBM]) have a low 5-year survival rate of 5.5%. In this study, the authors tried to improve currently used therapies by identification of a therapeutic target, IGFBP3, for glioma treatment. METHODS: IGFBP3 RNA expression in 135 patients newly diagnosed with glioma was correlated with clinicopathological factors. Immunohistochemical analysis was performed to determine IGFBP3 protein expression in glioma specimens. The effect of IGFBP3 depletion on cell proliferation was examined using IGFBP3 knockdown glioma cells. Intracranial infusion of IGFBP3 siRNAs was performed to evaluate the effect of IGFBP3 depletion in mouse intracranial xenograft models. RESULTS: We demonstrated higher IGFBP3 expression in GBM than in tumor margin and grade II glioma. IGFBP3 expression was not only positively correlated with tumor grades but also associated with tumor histology and IDH1/2 mutation status. Additionally, higher IGFBP3 expression predicted shorter overall survival in glioma and GBM proneural subgroup patients. In vitro cell culture studies suggested IGFBP3 knockdown suppressed cell proliferation and induced cell cycle G2/M arrest as well as apoptosis in glioma cells. Also, accumulation of DNA double-strand breaks and γH2AX was observed in IGFBP3 knockdown cells. IGFBP3 knockdown delayed in vivo tumor growth in mouse subcutaneous xenograft models. Furthermore, convection-enhanced delivery of IGFBP3 siRNA to mouse brain suppressed intracranial tumor growth and prolonged survival of tumor-bearing mice. CONCLUSIONS: Our findings suggest IGFBP3 predicts poor outcome of glioma patients and is a potential therapeutic target for which depletion of its expression suppresses tumor growth through inducing apoptosis and accumulation of DNA damage in glioma cells.
引用
- Chen CH, Chen PY, Lin YY, et al. Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma. J Neurosurg. 2019. PMID: 30641835. doi:10.3171/2018.8.JNS181217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。